Loading…

Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity

Pyrrolobenzoxazepinones (PBOs) represent a new class of human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) whose prototype is 5. Molecular modeling studies based on the X-ray structures of HIV-1 RT prompted the synthesis of novel analogues which...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2005-11, Vol.48 (23), p.7153-7165
Main Authors: Fattorusso, Caterina, Gemma, Sandra, Butini, Stefania, Huleatt, Paul, Catalanotti, Bruno, Persico, Marco, De Angelis, Meri, Fiorini, Isabella, Nacci, Vito, Ramunno, Anna, Rodriquez, Manuela, Greco, Giovanni, Novellino, Ettore, Bergamini, Alberto, Marini, Stefano, Coletta, Massimo, Maga, Giovanni, Spadari, Silvio, Campiani, Giuseppe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pyrrolobenzoxazepinones (PBOs) represent a new class of human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) whose prototype is 5. Molecular modeling studies based on the X-ray structures of HIV-1 RT prompted the synthesis of novel analogues which were tested as anti-HIV agents. The PBO derivatives specifically designed to target the highly conserved amino acid residues within the β12-β13 hairpin, namely primer grip, proved to be very potent against the most common mutant enzymes, including the highly resistant K103N mutant strain. Structure−activity relationships (SARs) are discussed in terms of a possible interaction with the RT binding site, depending on the nature of the substituents at C-6. Among the pyrrolobenzoxazepines investigated, 15c appeared to be the most promising NNRTI of the series characterized by potent antiviral activity, broad spectrum, and low cytotoxicity. 15c showed synergistic antiviral activity with AZT.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm050257d